Intellectual Property & Copyright

Overview

GNQ Insilico Inc. (“Company”) is committed to protecting its intellectual property and maintaining the confidentiality of its proprietary technologies. This page outlines our intellectual property rights, the scope of our protections, and the terms under which our materials may be used.

Ownership and Protection

GNQ Insilico Inc. owns all right, title, and interest in and to:

• The Drug Assessment Platform and all component technologies
• All algorithms, machine learning models, and analytical methodologies
• The proprietary systems biology knowledge graph
• All documentation, source code, and technical specifications
• All trade secrets, confidential information, and know-how
• All trademarks, service marks, logos, and brand assets
• All data models, analytical frameworks, and predictive systems
• All improvements, modifications, and derivative works

Legal Protection

These materials are protected by U.S. and international copyright law, patent law, trade secret law, and trademark law. Protection includes:

• Federal copyright registration where applicable
• Patent applications covering novel methodologies
• Trade secret protections under the Uniform Trade Secrets Act (UTSA)
• Common law protections available in all jurisdictions

Restrictions on Use

Without express written permission from GNQ Insilico Inc., you may not:

• Reproduce, distribute, transmit, or publish any portion of our materials
• Create derivative works, modifications, or adaptations
• Reverse engineer, decompile, disassemble, or attempt to discover proprietary processes
• Use our intellectual property for any commercial purpose without authorization
• Remove, obscure, or alter any copyright, patent, or proprietary notices
• Lease, sell, rent, or transfer our intellectual property to third parties
• Bypass, circumvent, or disable any security measures or technical protections
• Attempt to gain unauthorized access to our platform, systems, or data

Authorized Use

Permitted Access

Access to GNQ Insilico materials, platforms, and technologies is granted solely to:

• Authorized partners under valid partnership or service agreements
• Licensed clients under applicable licensing agreements
• Authorized investors who have entered into confidentiality agreements
• Employees and contractors with proper authorization

Conditions of Use

All authorized access and use must:

• Comply with all terms and conditions established by GNQ Insilico Inc.
• Be limited to the specific purpose authorized in the applicable agreement
• Include safeguards to prevent unauthorized disclosure
• Maintain the confidentiality of all proprietary information
• Be subject to monitoring and auditing by GNQ Insilico Inc.

Patents and Patent Applications

Patent Status

Patent Pending. GNQ Insilico Inc. has filed patent applications covering the Drug Assessment Platform’s methodologies, processes, and technical innovations. These applications include:

• Pathway-driven multi-omics integration methodologies
• Causal inference engines for drug response prediction
• Quantum-enhanced optimization algorithms
• Knowledge graph architecture and data model
• Clinical trial design optimization systems

Patent Rights

Once issued, these patents will provide additional legal protection for our core technologies. GNQ Insilico Inc. reserves all rights under patent law, including the right to exclude others from making, using, selling, or offering for sale the patented inventions.

Patent information will be updated on this page as applications proceed through examination and issuance. Specific patent numbers and details will be provided upon request to authorized parties.

Trademarks

Registered and Unregistered Marks

GNQ Insilico Inc. owns the following trademarks:

• GNQ Insilico® – Company name and brand
• Drug Assessment Platform™ – Core product name
• GNQ™ – Abbreviated company mark
• All associated logos, wordmarks, and design elements

Usage Rights

These marks are registered trademarks of GNQ Insilico Inc. in the United States and other countries. Use of our marks without authorization is prohibited. Authorized partners may use GNQ marks only in accordance with specific brand guidelines provided by GNQ Insilico Inc.

Third-Party Marks

All other trademarks, service marks, logos, and brand names referenced on this website are the property of their respective owners. GNQ Insilico Inc. claims no ownership or affiliation with third-party marks unless expressly stated.

Data Privacy and Security

Confidential Information Handling

GNQ Insilico Inc. maintains strict protocols for handling confidential information, including:

• De-identified and anonymized patient data in compliance with HIPAA
• Secure data storage with encryption at rest and in transit
• Limited access to authorized personnel with need-to-know
• Regular security audits and vulnerability assessments
• Compliance with GDPR, CCPA, and applicable privacy regulations

Data Sovereignty

Client data remains under client control. GNQ Insilico Inc. provides federated learning and data sovereignty options to ensure compliance with regulatory requirements and client preferences.

For detailed information regarding our privacy practices, please refer to our Privacy Policy available on our website at www.gnq.ai.

Enforcement and Violations

Monitoring and Enforcement

GNQ Insilico Inc. actively monitors for unauthorized use and infringement of its intellectual property rights. We pursue all available legal remedies against infringers, including:

• Cease and desist notices
• Injunctive relief to prevent ongoing infringement
• Civil litigation for damages
• Criminal prosecution where applicable
• Cooperation with law enforcement and regulatory authorities

Reporting Infringement

If you believe your intellectual property rights have been infringed by GNQ Insilico Inc., or if you have information about unauthorized use of our intellectual property, please contact us immediately at legal@gnq.ai.

Contact Information

Disclaimers and Limitations

No License Grant

Access to this website or our materials does not grant you any license, right, or permission to use our intellectual property except as expressly authorized in writing by GNQ Insilico Inc.

Accuracy of Information

While we strive to keep the information on this page accurate and current, GNQ Insilico Inc. makes no representations or warranties regarding the accuracy, completeness, or timeliness of the intellectual property information contained herein.

Changes to Terms

GNQ Insilico Inc. reserves the right to modify this intellectual property notice at any time without notice. Your continued access to our materials constitutes acceptance of any modifications.

Governing Law

This intellectual property notice is governed by and construed in accordance with the laws of the State of California, without regard to its conflict of law principles. Any disputes shall be resolved in the state or federal courts located in California.

Acknowledgment